Semaglutide leads to significant weight loss in Type 2 diabetes patients
Article by Bruce Sylvester. Patients diagnosed with type 2 diabetes and treated with weekly semaglutide have achieved an average weight loss of almost 10kg, researchers reported on March 2, 2021 in The Lancet. Put in other terms, two-thirds of subjects treated with weekly injections of a 2.4mg semaglutide lost at least 5% of their body weight and achieved significant improvement in […]
Recent Comments